Bullous pemphigoid in a 3-month-old infant after vaccination.
C Cortés-Pinto, M Baradad Brusau, F Vilardell Vilellas, J M Mascaró Galy, N Arco Huguet, X Soria Gili
Author Information
- C Cortés-Pinto: Department of Dermatology, University Hospital Arnau de Vilanova, LLeida, Spain. ORCID
- M Baradad Brusau: Department of Dermatology, University Hospital Arnau de Vilanova, LLeida, Spain.
- F Vilardell Vilellas: Department of Pathology , University Hospital Arnau de Vilanova, LLeida, Spain.
- J M Mascaró Galy: Department of Dermatology, Hospital Clinic Barcelona, Barcelona, Spain.
- N Arco Huguet: Department of Pediatrics, University Hospital Arnau de Vilanova, LLeida, Spain.
- X Soria Gili: Department of Dermatology, University Hospital Arnau de Vilanova, LLeida, Spain.
No abstract text available.
Anti-Infective Agents
Autoantibodies
Blister
Dapsone
Humans
Infant
Male
Pemphigoid, Bullous
Skin Diseases, Vesiculobullous
Treatment Outcome
Urticaria
Vaccination
Anti-Infective Agents
Autoantibodies
Dapsone
